Leader Biography
Drew Sansone
Senior Vice President, Regulatory Affairs
Drew Sansone serves as Alkermes’ Senior Vice President, Regulatory Affairs. In this role, Mr. Sansone leads the company's Regulatory Strategy, Advertising and Promotion, Regulatory Operations, CMC Regulatory, Regulatory Policy, Medical Writing and Scientific Operations and CMC Governance functions.
Mr. Sansone brings over 25 years of global regulatory affairs experience spanning multiple therapeutic areas and at companies of various sizes. He has experience overseeing all areas of regulatory and has led the submission and approval process for multiple drug products in neurology, rare disease, Hepatitis C, anti-infectives and oncology. Prior to Alkermes, Mr. Sansone held various senior regulatory leadership roles at Tango Therapeutics, Inc., Ipsen Biopharmaceuticals, Inc., Abbvie, Inc., Tengion, Inc., Vicuron Pharmaceuticals, Inc., and AstraZeneca plc.
Mr. Sansone received a bachelor’s degree in Psychology (with concentration in Business Administration) from Siena College and a master’s degree in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy.
Mr. Sansone brings over 25 years of global regulatory affairs experience spanning multiple therapeutic areas and at companies of various sizes. He has experience overseeing all areas of regulatory and has led the submission and approval process for multiple drug products in neurology, rare disease, Hepatitis C, anti-infectives and oncology. Prior to Alkermes, Mr. Sansone held various senior regulatory leadership roles at Tango Therapeutics, Inc., Ipsen Biopharmaceuticals, Inc., Abbvie, Inc., Tengion, Inc., Vicuron Pharmaceuticals, Inc., and AstraZeneca plc.
Mr. Sansone received a bachelor’s degree in Psychology (with concentration in Business Administration) from Siena College and a master’s degree in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy.